PRLR and breast carcinoma: In a study conducted by Ashley Sutherland, the researchers investigated the levels of prolactin receptor (PRLR) using quantitative immunohistochemistry in 134 primary breast cancer samples and matched samples of 17 primary breast cancer and bone metastasis.